<unk>  is metabolized in the liver by the cytochrome P450 enzyme CYP3A4. When administered concomitantly with drugs that inhibit CYP3A4, such as ketoconazole, the metabolism of<unk>  is impaired, leading to an increase in its concentration in the body and a reduction in its excretion. As stated above,<unk>  may also prolong the QT interval. Therefore, administering it concomitantly with drugs which also have this effect, such as moxifloxacin or pimozide, can theoretically increase the risk of arrhythmia.
Solifenacin
Zoliflodacin
Proglumetacin
Revefenacin
Darifenacin
Tofenacin
Arbekacin
Sakacin